相似文献
1
Association of Suboptimal Antiretroviral Therapy Adherence With Inflammation in Virologically Suppressed Individuals Enrolled in the SMART Study.
Open Forum Infect Dis. 2017 Dec 22;5(1):ofx275. doi: 10.1093/ofid/ofx275. eCollection 2018 Jan.
2
A simple self-reported adherence tool as a predictor of viral rebound in people with viral suppression on antiretroviral therapy.
HIV Med. 2016 Feb;17(2):124-32. doi: 10.1111/hiv.12284. Epub 2015 Jul 17.
3
Incomplete ART adherence is associated with higher inflammation in individuals who achieved virologic suppression in the START study.
J Int AIDS Soc. 2019 Jun;22(6):e25297. doi: 10.1002/jia2.25297.
4
Brief Report: Higher ART Adherence Is Associated With Lower Systemic Inflammation in Treatment-Naive Ugandans Who Achieve Virologic Suppression.
J Acquir Immune Defic Syndr. 2018 Apr 15;77(5):507-513. doi: 10.1097/QAI.0000000000001629.
5
Suboptimal Adherence to Combination Antiretroviral Therapy Is Associated With Higher Levels of Inflammation Despite HIV Suppression.
Clin Infect Dis. 2016 Dec 15;63(12):1661-1667. doi: 10.1093/cid/ciw650. Epub 2016 Sep 22.
6
Long-term virologic responses to antiretroviral therapy among HIV-positive patients entering adherence clubs in Khayelitsha, Cape Town, South Africa: a longitudinal analysis.
J Int AIDS Soc. 2020 May;23(5):e25476. doi: 10.1002/jia2.25476.
7
Brief Report: Ritonavir Concentrations in Hair Predict Virologic Outcomes in HIV-Infected Adolescents With Virologic Failure on Atazanavir-Based or Ritonavir-Based Second-Line Treatment.
J Acquir Immune Defic Syndr. 2021 Oct 1;88(2):181-185. doi: 10.1097/QAI.0000000000002742.
8
Recruitment of Youth Living With HIV to Optimize Adherence and Virologic Suppression: Testing the Design of Technology-Based Community Health Nursing to Improve Antiretroviral Therapy (ART) Clinical Trials.
JMIR Res Protoc. 2020 Dec 11;9(12):e23480. doi: 10.2196/23480.
9
Incomplete Antiretroviral Therapy Adherence Is Associated with Lower CD4-CD8 Ratio in Virally Suppressed Patients with HIV Infection in Mexico.
AIDS Res Hum Retroviruses. 2023 Mar;39(3):136-144. doi: 10.1089/AID.2021.0179. Epub 2023 Feb 15.
10
High residual inflammation despite HIV viral suppression: Lessons learned from real-time adherence monitoring among people with HIV in Africa.
HIV Med. 2022 May;23(5):465-473. doi: 10.1111/hiv.13200. Epub 2021 Oct 26.
引用本文的文献
1
Beyond Undetectable: Modeling the Clinical Benefit of Improved Antiretroviral Adherence in Persons With Human Immunodeficiency Virus With Virologic Suppression.
Open Forum Infect Dis. 2023 May 3;10(5):ofad230. doi: 10.1093/ofid/ofad230. eCollection 2023 May.
2
Meaningful cognitive decline is uncommon in virally suppressed HIV, but sustained impairment, subtle decline and abnormal cognitive aging are not.
EClinicalMedicine. 2022 Dec 26;56:101792. doi: 10.1016/j.eclinm.2022.101792. eCollection 2023 Feb.
3
Incomplete Antiretroviral Therapy Adherence Is Associated with Lower CD4-CD8 Ratio in Virally Suppressed Patients with HIV Infection in Mexico.
AIDS Res Hum Retroviruses. 2023 Mar;39(3):136-144. doi: 10.1089/AID.2021.0179. Epub 2023 Feb 15.
4
Translating the observed differences in interleukin-6 levels between some antiretroviral regimens into potential long-term risk of serious non-AIDS events: A modeling study.
Front Immunol. 2022 Nov 8;13:976564. doi: 10.3389/fimmu.2022.976564. eCollection 2022.
5
Factors Associated with Severe COVID-19 and Post-Acute COVID-19 Syndrome in a Cohort of People Living with HIV on Antiretroviral Treatment and with Undetectable HIV RNA.
Viruses. 2022 Feb 28;14(3):493. doi: 10.3390/v14030493.
6
Cardiovascular Implications of Immune Disorders in Women.
Circ Res. 2022 Feb 18;130(4):593-610. doi: 10.1161/CIRCRESAHA.121.319877. Epub 2022 Feb 17.
7
Current Considerations for Clinical Management and Care of People with HIV: Findings from the 11th Annual International HIV and Aging Workshop.
AIDS Res Hum Retroviruses. 2021 Nov;37(11):807-820. doi: 10.1089/AID.2021.0059. Epub 2021 Sep 20.
8
Association of Incomplete Adherence to Antiretroviral Therapy With Cardiovascular Events and Mortality in Virologically Suppressed Persons With HIV: The Swiss HIV Cohort Study.
Open Forum Infect Dis. 2021 Jan 21;8(2):ofab032. doi: 10.1093/ofid/ofab032. eCollection 2021 Feb.
9
Partial Normalization of Biomarkers of Inflammation and Immune Activation Among Virally Suppressed Men With HIV Infection and High ART Adherence.
Open Forum Infect Dis. 2020 Mar 23;7(4):ofaa099. doi: 10.1093/ofid/ofaa099. eCollection 2020 Apr.
10
The Video intervention to Inspire Treatment Adherence for Life (VITAL Start): protocol for a multisite randomized controlled trial of a brief video-based intervention to improve antiretroviral adherence and retention among HIV-infected pregnant women in Malawi.
Trials. 2020 Feb 19;21(1):207. doi: 10.1186/s13063-020-4131-8.
本文引用的文献
1
Suboptimal Adherence to Combination Antiretroviral Therapy Is Associated With Higher Levels of Inflammation Despite HIV Suppression.
Clin Infect Dis. 2016 Dec 15;63(12):1661-1667. doi: 10.1093/cid/ciw650. Epub 2016 Sep 22.
2
Immunologic Biomarkers, Morbidity, and Mortality in Treated HIV Infection.
J Infect Dis. 2016 Oct 1;214 Suppl 2(Suppl 2):S44-50. doi: 10.1093/infdis/jiw275.
3
Weekends-off efavirenz-based antiretroviral therapy in HIV-infected children, adolescents, and young adults (BREATHER): a randomised, open-label, non-inferiority, phase 2/3 trial.
Lancet HIV. 2016 Sep;3(9):e421-e430. doi: 10.1016/S2352-3018(16)30054-6. Epub 2016 Jun 20.
4
Interleukin 6 Is a Stronger Predictor of Clinical Events Than High-Sensitivity C-Reactive Protein or D-Dimer During HIV Infection.
J Infect Dis. 2016 Aug 1;214(3):408-16. doi: 10.1093/infdis/jiw173. Epub 2016 Apr 30.
5
Persistent HIV-1 replication maintains the tissue reservoir during therapy.
Nature. 2016 Feb 4;530(7588):51-56. doi: 10.1038/nature16933. Epub 2016 Jan 27.
6
A simple self-reported adherence tool as a predictor of viral rebound in people with viral suppression on antiretroviral therapy.
HIV Med. 2016 Feb;17(2):124-32. doi: 10.1111/hiv.12284. Epub 2015 Jul 17.
7
Factors Associated With Plasma IL-6 Levels During HIV Infection.
J Infect Dis. 2015 Aug 15;212(4):585-95. doi: 10.1093/infdis/jiv123. Epub 2015 Feb 26.
8
The effect of HAART-induced HIV suppression on circulating markers of inflammation and immune activation.
AIDS. 2015 Feb 20;29(4):463-71. doi: 10.1097/QAD.0000000000000545.
9
Differential Reduction in Monocyte Activation and Vascular Inflammation With Integrase Inhibitor-Based Initial Antiretroviral Therapy Among HIV-Infected Individuals.
J Infect Dis. 2015 Aug 1;212(3):345-54. doi: 10.1093/infdis/jiv004. Epub 2015 Jan 12.
10
Elevated levels of monocyte activation markers are associated with subclinical atherosclerosis in men with and those without HIV infection.
J Infect Dis. 2015 Apr 15;211(8):1219-28. doi: 10.1093/infdis/jiu594. Epub 2014 Oct 30.
Zotero 插件